Adjuvant therapy after curative resection for hepatocellular carcinoma associated with hepatitis virus
about
Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinomaCancer and liver cirrhosis: implications on prognosis and managementMicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X.Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transitionTreatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work reviewDecrypting cryptogenic hepatocellular carcinoma: clinical manifestations, prognostic factors and long-term survival by propensity score model.Long-term survival in patients with T2 hepatocellular carcinoma after primary curative resection can be further stratified by tumor size.Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors.Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinomaTreatment of Liver Cancer.MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2.Establishment of experimental implantation tumor models of hepatocellular carcinoma in Wistar rats.Liver cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.Long-Term Prognostic Factors after Hepatic Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma, with a Special Reference to Viral Status
P2860
Q26799056-8C022600-13BF-446B-B87D-7A45FAB341CAQ28068579-03B04525-FFF1-4FB9-875D-2FA1B9B3165EQ33775464-2D5BA29A-C6AB-4A71-ADA2-C5B1178D2562Q34932446-34FFE91E-6C90-40C1-91BD-49F7D9BD0686Q35037545-2BBAEF29-E11F-4CD0-BF37-28273FDB6414Q35107166-93F8F1D5-1833-41C1-9E9E-598181DAC1EAQ36152525-59490FF4-16E8-40C7-B713-8701076A23BBQ37407115-469F1B76-B01C-4AF0-A4F7-1F521A812B45Q37716493-A0BED9C7-0211-46F9-ADF0-4E6E90A23854Q38549768-C2FF1AEF-7C3A-4E20-A1A1-43FF8AEB2785Q38851292-7845B831-301A-4ECB-B988-0814E3D400D9Q38986377-6D42D286-8442-4784-AAB7-C2A846C7B97AQ46821226-2B28A966-CFD4-4D36-A68E-4F7EF1AA01BBQ57494812-CEE3BC67-2D0B-404E-B5D7-3064B8E77DAF
P2860
Adjuvant therapy after curative resection for hepatocellular carcinoma associated with hepatitis virus
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Adjuvant therapy after curativ ...... ssociated with hepatitis virus
@ast
Adjuvant therapy after curativ ...... ssociated with hepatitis virus
@en
Adjuvant therapy after curativ ...... ssociated with hepatitis virus
@nl
type
label
Adjuvant therapy after curativ ...... ssociated with hepatitis virus
@ast
Adjuvant therapy after curativ ...... ssociated with hepatitis virus
@en
Adjuvant therapy after curativ ...... ssociated with hepatitis virus
@nl
prefLabel
Adjuvant therapy after curativ ...... ssociated with hepatitis virus
@ast
Adjuvant therapy after curativ ...... ssociated with hepatitis virus
@en
Adjuvant therapy after curativ ...... ssociated with hepatitis virus
@nl
P2093
P2860
P356
P1433
P1476
Adjuvant therapy after curativ ...... ssociated with hepatitis virus
@en
P2093
Chikaharu Sakata
Shigekazu Takemura
Shoji Kubo
Takahiro Uenishi
Yorihisa Urata
P2860
P356
10.1159/000346214
P407
P577
2013-01-01T00:00:00Z